Oscillometric blood pressure (BP) measurement devices are increasingly replacing standard mercury sphygmomanometers and generalizability of validation studies to other environments, for example, national survey environments, is assumed. We compared BP measurements according to two highly standardized German national survey BP protocols: a standard mercury sphygmomanometer and an oscillometric device, Datascope Accutorr Plus, each with specific manufacturerprovided cuffs and cuff-selection rules. A sample of 105 adults were subjected to alternate same-arm BP measurements according to the principles of the International Protocol revision 2010 for the validation of BPmeasuring devices in adults of the European Society of Hypertension. In all, 315 BP measurement pairs were obtained. The mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were higher by the standard mercury old protocol and increased with BP, age, and pulse pressure, and were associated with the ratios of the cuff width to the arm circumference. The mean systolic difference (datascope new protocol − standard mercury old protocol) in participants with old protocol: for SBP < 120 was − 3.5 ± 4.9 mmHg (n = 162), for SBP 120-139 (n = 108) was − 6.4 ± 5.8 mmHg, and for SBP ≥ 140 (n = 45) was − 11.9 ± 7.2 mmHg. For DBP < 80/80-89/ ≥ 90 in 230/67/18 participants, the differences were − 1.9 ± 5.0/ − 6.8 ± 5.9/ − 7.6 ± 5.2 mmHg. A calibration formula for SBP derived from linear regression modeling includes SBP, sex, age, pulse pressure, and the difference in the cuff-width to arm-circumference ratios for the two devices (for DBP without age). Our study suggests that even in a highly standardized national survey environment, reported agreement from validation studies may not be replicable and comparisons in the specific clinical or research setting can be useful before replacing the mercury device completely. Blood Press Monit 20:39-42
Introduction
Detection of a population-wide blood pressure (BP) change of even 2 mmHg is important as it is associated with a change in stroke mortality of 10% and coronary heart disease mortality of 7% [1] . Therefore, it is important to differentiate real changes from measurement bias. One form of measurement bias, observer bias, can be avoided by replacing mercury sphygmomanometers by automated oscillometric devices, but new measurement bias may arise depending on the agreement of the specific automated device with the standard mercury auscultatory method.
This study is a methodological study designed to evaluate the comparability of BP data from two national health surveys in Germany after a change from the standard mercury sphygmomanometer to a validated automated oscillometric device, the Datascope Accutorr Plus, including a change of manufacturer-provided cuffs and cuff-selection rules [2] .
Materials and methods
The study design followed the principles of the International Protocol revision 2010 for the validation of BP-measuring devices in adults of the European Society of Hypertension (ESH-IP2) [3] . The standardization of BP measurement was adopted from the two most recent German national examination surveys for adults conducted in 1998 (GNHIES89, old protocol) and in 2008-2011 (DEGS1, new protocol) [2] . The old and the new protocol differed, however, by the device, the cuffs and the instructions for selection of the cuffs (Table 1) . Participants sat and relaxed for at least 5 min on a heightadjustable chair, their back supported. The elbow was slightly bent and lying on a table at the level of the right atrium. Both feet were straight on the floor and the legs were not crossed. The correct cuff size (Table 1) was identified by measuring the arm circumference (AC) between the acromion and the olecranon. The correct position of the cuff above the brachial artery was additionally checked with a mark on the cuff, which was in the middle of the inflatable bladder length. Deviations from the ESH-IP2 were relaxing time of 5 min instead of 10-15 min and standard mercury old protocol cuff length encircling 73-127% of the AC instead of 80-100%.
The study was approved by the Ethical Committee of Charité University Medicine, Berlin, and by the German Federal Commissioner for Data Protection and Freedom of Information. Informed consent and assent were obtained from all participants.
A convenience sample of 105 adults aged 21-64 years [65 women, 40 men, age 41 12 years (mean SD), mainly white-collar workers] was included in the study, providing a total of 315 BP measurement pairs from alternate serial same-arm BP measurements with the two devices. Individuals with arrhythmia or a pacemaker (ascertained by personal interview and pulse palpation) as well as pregnant women were excluded from the study.
Observer training for the auscultatory method included British Hypertension Society (BHS) interactive tutorials and tests (http://www.bhsoc.org/resources/bhs-dvd/), other audiovisual training materials and supervised training. Auscultatory readings were obtained by two independent observers simultaneously using a Y-tube stethoscope and were recorded to the nearest 2 mmHg. The two observers were blinded to each other's readings and entered the auscultatory readings independently into an electronic form. An alarm was set in the electronic form when observer disagreement from the simultaneous auscultatory reading exceeded 4 mmHg and the measurement had to be repeated. The maximum number of measurement repetitions because of observer disagreement was two; otherwise, measurements in that particular participant had to be discontinued. A series of nine sequential same-arm BP measurements was aimed for in each participant starting with the standard mercury sphygmomanometer (Erkameter 3000; Erka, Bad Tölz, Germany). The first measurement with each device was not used for analysis. Measurements were at least 30 s apart to avoid venous congestion, but not more than 60 s to avoid increased variability, and these time limits were monitored using software programmed for this study.
The analysis was based on BP measurement pairs as outlined in the ESH-IP2 protocol [3] . Each datascope measurement was compared with the nearest of the previous and the next mercury sphygmomanometer measurement (mean from the two simultaneous observer readings). Only participants with three valid measurement pairs were included. IBM SPSS statistics version 20 (IBM Corp., Armonk, New York, USA) was used for analyses.
Results
The analysis was based on 315 measurement pairs from 105 participants ( Table 1 ). The mean observer difference for auscultatory BP was − 0.08 1.8 mmHg for systolic blood pressure (SBP) and − 0.13 2.0 mmHg for diastolic blood pressure (DBP). The mean SBP and DBP were higher by the old protocol than by the new protocol, and the difference increased with BP and AC ( Table 2 ). The mean systolic difference (datascope new protocol − standard mercury old protocol) was − 3.50 4.91 mmHg for optimal SBP, − 6.38 5.78 mmHg for prehypertensive SBP and − 11.89 7.23 mmHg for hypertensive SBP (diastolic − 1.91 5.03, − 6.75 5.93, and − 7.61 5.20 mmHg). More than one-third of the hypertensive study participants had device differences in SBP of more than 15 mmHg.
A calibration formula was derived to predict new protocol SBP and DBP values from old protocol SBP and DBP values with linear regression models. Parameters considered for the model were old protocol SBP and DBP, respectively, age, sex, pulse pressure (SBP − DBP), and variables relating to cuffs and AC [cuffs, AC, cuff-width to arm-circumference ratio (CWACR), and cuff-length to arm-circumference ratio for both devices and their differences (datascope − standard mercury)]. Parameters with P-value less than 0.05 were retained in the model. The final models were as follows: 
Discussion
This study shows that after replacing a standard mercury sphygmomanometer with an automatic oscillometric device in a highly standardized national survey environment, the disagreement of BP measurement may be much larger than expected from published validation studies.
A validation study of the Datascope Accutorr Plus (Datascope Corporation, Mahwah, New Jersey, USA) [4] had shown an observer-device agreement of − 0.04 7.93 mmHg for SBP and 0.35 5.75 mmHg for DBP. The criteria of the Association for the Advancement of Medical Instrumentation (AAMI, mean difference ≤ 5 mmHg and SD ≤ 8 mmHg) and BHS criteria (grade A both for SBP and DBP, i.e. absolute difference within 5 mmHg in ≥ 60% of measurement pairs, within 10 mmHg in ≥ 85% and within 15 mmHg in ≥95%) were fulfilled. A second validation study in adults [5] focused on hypertensive and hypotensive patients and on patients with small ACs, and reported largely similar results to the first one. The device was chosen for national health surveys in Germany in 2002 on the basis of a clinical review with recommendations of the ESH [6] .
In our study, which replicates our national health survey environment and follows the ESH-IP2 protocol, the mean measurement difference increased with BP from 3.5 mmHg in normotensive to 12 mmHg in hypertensive participants. Several reasons may have contributed towards this surprising disagreement: (a) differences between the device-specific cuffs, (b) residual differences between the standardization in a validation laboratory and a highly standardized national survey environment and (c) difficulties in replicating validation results from one and a half decades ago. Of note, in previous validation studies, only the mean agreement was very good, but SDs were large. Agreement was not presented stratified by BP and Bland-Altman plots suggested higher disagreement with higher BP. One difference between our study and previous validation studies is the use of different cuff sizes for each device. Maintaining identical bladder sizes and identical cuff-selection rules over decades of national health surveys has proved impossible as manufacturer-provided cuff sizes changed frequently and cuff-selection rules had to be adjusted to current guidelines. However, the main contributors towards measurement disagreement were BP level and pulse pressure. This has been reported before [7, 8] , but it has not been pointed out in validation studies. Protocols for validation studies do not require reporting of stratified results for different BP levels.
A major limitation of our study is that recruitment in the high BP and high age range was difficult and did not reach ESH-IP2 recommendations. Therefore, calibration of severely hypertensive measurements (≥160/110 mmHg) with the calibration formula from this study relies on fewer measurements and is likely to be less robust than calibration of lower BPs. In addition, the correction formulas presented here are only valid for the device studied in combination with the cuff studied, which is a rare combination. However, the variables in the formulas are likely to be relevant for similar studies, in particular, cuff-related variables and pulse pressure, which have not been considered in the development of previous correction formulas [9, 10] . Of note, validation studies have shown that oscillometric devices can overestimate or underestimate BP depending on the specific device (http://www.dableducational.org). The influence of device-related and cuff-related measurement differences can add or can attenuate each other.
Conclusion
Our study reaffirms that before replacing the mercury device completely, old mercury readings and new oscillometric readings should be compared in the specific setting [11] . Lower agreement may be suspected in particular if there is a concurrent change of cuffs, if the validation studies are older (i.e. the device algorithm could have changed in the meantime), as well as in populations with hypertension and with comorbidities associated with increased pulse pressure such as diabetes or renal insufficiency.
